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Since hypoxia might contribute to the development of muscle atrophy, we wished to provide direct
evidence linking hypoxia to muscle atrophy. By evaluating protein degradation and synthesis in
hypoxic myotubes we found a signiﬁcant reduction in total protein content. Using functional assays
we observed protein degradation elevation in the ﬁrst 24 h while synthesis was maintained during
this period and then signiﬁcantly decrease at 48 h. These results demonstrate a temporal regulation
of protein homeostasis, whereby elevated protein degradation is followed by a reduction in synthe-
sis. These results are comparable to the cellular adaptation seen during development of muscle
atrophy.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Muscle atrophy is a common clinical manifestation occurring in
a variety of hypoxemic conditions, including chronic obstructive
pulmonary disease (COPD) [1–3]. In these subjects, peripheral
muscle wasting decreases functional capacity and increases mor-
tality [4]. We and others have hypothesized that hypoxemia and
the resulting tissue hypoxia is among the factors that might con-
tribute for the development of muscle atrophy [3,5]. However, this
statement has not been directly addressed.
Muscle mass maintenance relies on a ﬁne regulation between
contractile protein degradation and synthesis. In wasting condi-
tions, contractile protein degradation is mostly achieved through
the activation of the ubiquitin-proteasome (Ub-P’some) [6]. Since
this system is unable to directly break up the actomyosin structure
found in myoﬁbrils [7], a preliminary rate-limiting step is required
to fragment actomyosin into substrates that will be degraded by
the Ub-P’some. Among these substrates, actin fragments represent
a reliable marker for contractile protein degradation [8].
The major cascade involved in protein synthesis is the insulin-
like growth factor-1 (IGF-1)/phosphatidylinositol-3 kinase (PI3K)/
Akt pathway. Akt is a kinase which, upon phosphorylation, ensureschemical Societies. Published by E
ry disease; Ub-P’some, ubiq-
le’s medium; E3, ubiquitin
3, glycogen synthase kinase-
hate buffered saline; PI3K,
. Debigaré).cell survival, differentiation and protein synthesis by modulating
the activity of numerous targets including glycogen synthase
kinase-3 (GSK-3) [9].
In this study, we aimed to provide direct evidences demonstrat-
ing that hypoxia is involved in the instigation of cellular events
compatible with the initiation and the development of muscle
atrophy. We hypothesized that hypoxic exposure of L6 myotubes
would result in an elevation of contractile protein degradation
and the activation of the Ub-P’some system with a concomitant
reduction in protein synthesis and activity of the IGF-1/PI3K/Akt
pathway.
2. Materials and methods
2.1. Cell culture and hypoxic exposures
L6 rat myoblasts (ATCC, Manassas, VA, USA) were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 1% glucose (Hy-
Clone, Logan, UT, USA), 10% fetal bovine serum, penicillin 50 U/ml,
and streptomycin 50 lg/ml (HyClone). Conﬂuent myoblasts (80%)
were placed in differentiation medium made of DMEM with 1%
glucose, 2% horse serum, penicillin 50 U/ml, and streptomycin
50 lg/ml. After 4 days, differentiated myotubes were transferred
to a chamber maintained at 1% O2, 5% CO2, 94% N2 (ProOx system,
BioSpherix, Redﬁeld, NY, USA). Prior to hypoxic exposure, differen-
tiation medium was replaced with medium preconditioned over-
night in 1% O2 atmosphere. After designated exposures, hypoxic
cells were lysed in 1% O2 atmosphere inside a C-Shuttle Glovebox
(Biospherix) according to the subsequent protocols.lsevier B.V. All rights reserved.
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Cell stress induced by hypoxia was assessed by measuring
lactate dehydrogenase (LDH) leakage [10] using LDH-Cytotoxicity
Assay Kit (BioVision, Mountain View, CA, USA) according to the
manufacturer’s instructions. For each experimental condition, per-
centage of cytotoxicity was calculated using the following formula:
(LDH media/(LDH media + LDH cells))  100. General appearance
of myotubes was examined using a Nikon Eclipse TE300 inverted
microscope (Nikon Corporation, Tokyo, Japan) and images were
captured with a Nikon 950 digital camera (Nikon Corporation).
Number of nucleus was assessed using 40,6-diamidino-2-phenylin-
dole (DAPI) staining (Invitrogen, Carlsbad, CA, USA). Brieﬂy, myotu-
bes were grown on four wells Lab-TekTM chamber slides (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). After designated expositions,
cells were ﬁxed with 2% paraformaldehyde for 15 min and DAPI
was added for 2 min at a ﬁnal concentration of 30 nM in phosphate
buffered saline (PBS) 1X supplemented with 1% bovine serum albu-
min. Images were captured using a Nikon Eclipse E600 microscope
(Nikon Corporation) and all nuclei from six random separate ﬁelds
were counted.
2.3. Actomyosin breakdown measurements
The 14-kDa actin fragment accumulation, an indicator of acto-
myosin degradation, was measured as previously described [8].
Cells were scrapped in a hypotonic lysis buffer [5 mM Tris–HCl
pH 8.0, 1 mM b-mercaptoethanol, 1% glycerol, 1 mM ethylenedia-
mine tetraacetic acid (EDTA), 1 mM EGTA, protease inhibitor cock-
tail set III (EMD biosciences, San Diego, CA, USA)]. After
centrifugation (13 000 rpm, 4 C, 10 min), supernatant was
collected for detection of accumulated 14-kDa actin fragment by
Western blot using an anti-actin antibody which recognizes the
carboxy-terminal 11 amino acids (1:500, #A2066; Sigma–Aldrich,
St. Louis, MO, USA). Anti-actin antibody was then detected using
a secondary antibody coupled with horseradish peroxidase
(1:5000, #7074; Cell Signaling Technology Inc.). Results were nor-
malized to tubulin (1:20 000; Sigma–Aldrich).
2.4. Proteasome activity assays
Proteasome activity assays were performed using a modiﬁed
protocol [11]. Brieﬂy, cells were washed in ice-cold PBS and
scrapped in lysis buffer [50 mM Tris–HCl pH 7.5, 5 mM MgCl2,
250 mM sucrose, 1 mM DTT, 200 lM PMSF, protease inhibitor
cocktail set III (EMD biosciences)]. Lysate was grinded on ice and
centrifuged (10 000g, 4 C, 20 min). Supernatant was collected
and centrifuged (100 000g, 4 C, 45 min). Resulting pellet was
resuspended [50 mM Tris–HCl pH 7.5, 5 mM MgCl2, 20% glycerol]
and 10 lg of protein was added to 50 ll of reaction buffer
[50 mM Tris–HCl pH 8, 10 mMMgCl2, 2U Apyrase (Sigma–Aldrich)]
containing either 100 lM Suc-LLVY-AMC or 600 lM Z-LLE-AMC
(Sigma–Aldrich) to quantify chymotrypsin-like and caspase-like
proteasomal activities, respectively. After 15 min of incubation at
37 C, ﬂuorescence was measured (excitation 360 nm, emission
460 nm) (Fluoroskan Ascent; Labsystems, Helsinki, Finland).
2.5. Real-time PCR
Total RNA was isolated using TRIzol Reagent (Invitrogen) and
its quantity and purity were determined by spectrophotometry.
Reverse transcription was performed using QuantitectTM Reverse
Transcription Kit (Qiagen, Valencia, CA, USA) according to the man-
ufacturer’s instruction. Real-time PCR was performed with the
QuantitectTM SYBR Green PCR Kit (Qiagen) in an Opticon 2 (MJ
Research, Waltham, MA, USA). 18S mRNA was used as an internalcontrol. Primers used were (sense and antisense, 50–30): Atrogin-1
gtccagagagtcggcaagtc, gtcggtgatcgtgagacctt (141pb); MuRF1
tgaccaaggaaaacagccaccag, tcactcttcttctcgtccaggatgg (88pb) [12];
18S acggaagggcaccaccagga, caccaccacccacggaatcg (127pb) [13].
Real-time PCR were analyzed using the 2D DCT method [14].
2.6. Protein synthesis measurements
Total protein synthesis was appraised by measuring cellular
incorporation of L-[2,3,4,5,6-3H]Phenylalanine (Amersham,
Buckinghamshire, UK). Myotubes grown in a six wells plate were
incubated in differentiation medium containing L-[2,3,4,5,6-3H]-
Phenylalanine (0.5 lCi/ml). Controls with the proteasome inhibitor
epoxomicin (10 nM) were used to inhibit proteolysis. In a subse-
quent step, cells were washed in ice-cold PBS and incubated
overnight in a lysis buffer [PBS + 1% SDS] at 4 C. L-[2,3,4,5,6-3H]-
Phenylalanine uptake was measured in the lysates using a
Tri-Carb 2100TR liquid scintillation counter (Perkin–Elmer Life
Sciences, Boston, MA, USA).
2.7. Western blotting
Myotubes were washed with ice-cold PBS and incubated on ice
in lysis buffer [10 mM Tris–HCl pH 7.4, 150 mM NaCl, 2 mM EDTA,
2% Triton X-100, protease inhibitor cocktail set III (EMD biosci-
ences), phosphatase inhibitor cocktail 1 and 2 (Sigma–Aldrich)]
for 30 min. Western blots were performed with 60 lg of whole cell
extracts using standard SDS–PAGE procedures. After transfer on a
nitrocellulose membrane, immunoblotting with anti-Akt
(1:2000), anti-phospho-Akt (Ser473) (1:1000), anti-GSK-3b
(1:1000) or anti-phospho-GSK-3b (1:1000) (Cell Signaling Technol-
ogy, Danvers, MA, USA) was performed. Proteins of interest were
detected using a secondary antibody coupled with horseradish per-
oxidase (1:5000, #7074; Cell Signaling Technology Inc.). Results
were normalized to tubulin (1:20 000; Sigma–Aldrich).
2.8. Akt kinase activity assays
Akt kinase activity was evaluated using an Akt Activity Immu-
noassay Kit (EMD biosciences) according to the manufacturer’s
instructions.
2.9. Statistical analyses
All statistical analyses were performed using JMP 7.0 (SAS
Institute, Cary, NC, USA). Comparisons of experimental conditions
were carried out by ANOVA. P-value <0.05 was considered
signiﬁcant.3. Results
3.1. Cell viability is minimally affected in hypoxic myotubes
We ﬁrst evaluated the hypoxic stress on myotubes by measur-
ing LDH leakage in the culture media as an indicator of mem-
brane integrity. In hypoxic myotubes, we found a signiﬁcant
increase in LDH leakage (31.5 ± 3.4%, n = 3; P < 0.05) after 48 h
of exposure when compared to matching normoxic controls
(Fig. 1A). Insigniﬁcant change was observed at 24 h (2.5 ± 1.6%,
n = 3; P > 0.05). Despite an increase in LDH leakage, the main cel-
lular architecture of myotubes is preserved even if minor to mod-
erate structural changes are observed after 48 h of hypoxic
exposure (Fig. 1B). Finally, nuclei number present at 48 h in hyp-
oxic myotubes (Fig. 1C) was decreased by 11.3% (n = 6, P < 0.05).
Overall, these results indicate that our hypoxic protocol has a sig-
Fig. 1. Chronic hypoxic exposure induces cellular injuries and slightly decreased cell viability. (A) Myotubes were either exposed to 21% or 1% O2 for 24 h or 48 h. LDH leakage
was measured as an indication of membrane integrity. Results are mean ± S.E.M. of three independent experiments. *P < 0.05. (B) Following exposure to 21% or 1% O2 for 24 h
or 48 h, cells were visualized on an inverted microscope as described in Section 2 and typical observations are depicted (200). (C) Myotubes were stained with DAPI
following 48 h incubation to 21% or 1% O2. Total nuclei per ﬁeld (200) were counted and results are mean ± S.E.M. of six random ﬁelds per condition. *P < 0.05
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exposure (LDH leakage) but minor effect on myotubes viability
(nuclei number). Based on this observation, we decided to further
investigate the direct effects of chronic hypoxia on protein
homeostasis in our model.3.2. Total protein is negatively affected by hypoxia
We evaluated the impact of hypoxia on myotubes protein con-
tent. To do so, we directly measured the total protein concentra-
tion in our protein extracts using a protein assay based on the
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CA, USA). After 24 h, we observed a 24% reduction of total protein
concentration in cells exposed to 1% O2 compared to 21% O2
(3.29 lg/ll ± 0.21 and 4.33 lg/ll ± 0.35, respectively; n = 11,
P < 0.05). This ﬁnding reinforced the notion that chronic hypoxia
could affect both protein degradation and synthesis.
3.3. Protein degradation increases in hypoxic myotubes
We assessed protein degradation in myotubes using two dis-
tinct methods. First, we quantiﬁed the accumulation of a 14-kDa
actin fragment. After 12 h of hypoxic exposure, myotubes had a
134% increase in actin fragment compared to cells exposed at
21% O2 (Fig. 2). This increase was maintained after 24 h (Fig. 2).
Since the Ub-P’some system plays a central role in muscle protein
degradation [6], we next evaluated chymotrypsin-like and cas-
pase-like proteasomal activities in our model. In myotubes ex-
posed to 1% O2 for 24 h, both activities were respectively
increased by 38% (P < 0.05) and 86% (P < 0.05) compared to cells
exposed to 21% O2 (Fig. 3).
Atrogin-1 and MuRF1 are two muscle speciﬁc ubiquitin ligases
(E3s) upregulated in various muscle atrophy models [15,16]. Their
role is to attach activated ubiquitin to targeted substrates that will
be degraded by the proteasome. We evaluated their mRNA expres-
sion at various time points in myotubes exposed to 1% O2. Atrogin-
1 level was signiﬁcantly increased by 100% (P < 0.05) after 24 h in
hypoxic conditions whereas MuRF1 level did not change (Fig. 4).
Taken as whole, these results are indicative of an increased po-
tential for protein degradation in hypoxic myotubes. To further ex-
plore the effect of hypoxia on intracellular protein balance, we
tested the hypothesis that protein synthesis was altered in hypoxic
conditions.
3.4. Protein synthesis is decreased in hypoxic myotubes
To directly measure total muscle protein synthesis, we assessed
L-[2,3,4,5,6-3H]Phenylalanine uptake at 21% and 1% O2. After 24 h,
a non-signiﬁcant decrease of 5% in L-[2,3,4,5,6-3H]Phenylalanine
uptake was observed in hypoxic conditions (data not shown).
However, after 48 h exposure, L-[2,3,4,5,6-3H]Phenylalanine incor-Fig. 2. Actomyosin fragmentation is accentuated in hypoxia. Myotubes were either expo
was assessed by Western blotting. The 21% O2 condition was set at 100% and compared
tubulin density and are mean ± S.E.M. of six independent experiments. *P < 0.05poration was signiﬁcantly decreased by 49% (P < 0.05) in hypoxic
myotubes (Fig. 5). Only protein synthesis was assessed since sim-
ilar rate of incorporation was measured when epoxomicin was
added to culture medium (Fig. 5). As a result, these ﬁndings are
indicative of impaired protein synthesis in hypoxic conditions.
Because the IGF-1/PI3K/Akt pathway plays a major role in pro-
tein synthesis, we sought to evaluate its activity in ourmodel. There
was a non-signiﬁcant trend towards a decrease in the phospho-Akt/
Total Akt ratio after 24 h at 1% O2 (Fig. 6A). When phosphorylated
and total Akt were analyzed separately, we found that both forms
were diminished at 1% O2 (57% and 40%, respectively), although
only the decrease in the phosphorylated form reached statistical
signiﬁcance (Fig. 6A). To conﬁrm these results, Akt kinase activity
was directly assessed and shown to be signiﬁcantly reduced after
24 h of exposure to 1% O2 as revealed by a lower phosphorylation
level of recombinant GSK-3a (Fig. 6B). We veriﬁed the phosphory-
lation level of GSK-3b, a downstream target of Akt, after 24 h of
hypoxic exposure. Phospho-GSK-3b/Total GSK-3b ratio was de-
creased by 36% (P < 0.05) in myotubes exposed to 1% O2 (Fig. 7).
Taken as whole, these results are indicative of a reduced poten-
tial for protein synthesis in hypoxic myotubes.
4. Discussion
Cells exposed to hypoxia turn on speciﬁc processes that allow
proper adaptation to survive [17]. This study provides, for the
ﬁrst time, direct evidences linking hypoxia to cellular responses
compatible with the initiation and the development of muscle
atrophy.
A change in either protein synthesis or degradation can have
dramatic effects on muscle mass. The signiﬁcant decrease in total
protein found in hypoxic myotubes was the ﬁrst indication that
protein homeostasis was perturbed. This study demonstrates that
hypoxia act directly on muscle cells by sequentially enhancing pro-
tein degradation and reducing protein synthesis.
4.1. Proteolysis activation
We found an increase in actomyosin breakdown, as revealed by
the signiﬁcant accumulation of the 14-kDa actin fragment. Thissed to 21% or 1% O2 for 12 h or 24 h. The accumulation of the 14-kDa actin fragment
to 1% O2 condition. Results are reported as a ratio of the actin fragment density on
Fig. 3. Proteasomal activities are increased in hypoxia. Proteasomal units were isolated from myotubes exposed 24 h at 21% O2 (light gray) or 1% O2 (dark gray) and the
chymotrypsin-like and caspase-like activities were determined as described in Section 2. The 21% O2 condition was set at 100% and compared to 1% O2 condition. Results are
reported as mean ± S.E.M. of three independent experiments. *P < 0.05 versus 21% O2 condition.
Fig. 4. Hypoxia increases Atrogin-1 mRNA expression. Myotubes were either exposed to 21% O2 or 1% O2 for the indicated period of time. Atrogin-1 and MuRF1 mRNA
expression levels were measured using 18S as internal control. The 21% O2 condition was set at 100% and compared to hypoxic exposures. Results are reported as
mean ± S.E.M. of four independent experiments. *P < 0.05 versus 21% O2 condition.
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plex found in myoﬁbrils, the fundamental contractile unit of mus-
cle cell. In a subsequent step, we directly assessed the activity of
the Ub-P’some system in hypoxic conditions. We found an increase
in proteasomal activity, as chymotrypsin-like and caspase-like
activities were both signiﬁcantly up-regulated. Higher proteasomal
activity is preceded by ubiquitination of targeted substrates and
Atrogin-1 and MuRF1 are key regulators of this process. Underhypoxic conditions, up-regulation of Atrogin-1 mRNA expression
level but not of MuRF1 was observed. Interestingly, the Atrogin-1
mRNA level reached in hypoxic conditions is comparable to the le-
vel previously reported in humans with muscle atrophy [18]. The
reported discordant regulation of Atrogin-1 and MuRF1 is not un-
ique and has been observed in both cellular [19] and human [20]
models. This observation suggests that Atrogin-1 could be the pref-
erential E3 activated in hypoxic muscle cells.
Fig. 5. Total protein synthesis is decreased in hypoxia. Total protein synthesis was evaluated by measuring the L-[2,3,4,5,6-3H]Phenylalanine uptake in myotubes exposed
either to 21% or 1% O2 for 48 h. The 21% O2 condition without epoxomicin was set at 100% and data are stated as relative changes compared to this condition. Results are
reported as mean ± S.E.M. of at least three independent experiments. P < 0.05 when the letters over the columns are different.
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Another key result of the present study is the 49% reduction in
total protein synthesis in hypoxic myotubes. Although we observe
an increase in LDH leakage at 48 h, this method is an imperfect
indicator of cell mortality in multinucleated cells. The 11.3% de-
crease in total nuclei suggests that leaking myotubes are still via-Fig. 6. Akt kinase activity is impaired in hypoxia. (A) Whole cell extracts were
blotted for phosphorylated and total Akt after 24 h exposition to 21% or 1% O2. The
21% O2 condition was set at 100% and compared to hypoxic exposures. Data are
presented as phospho-Akt/total Akt ratios. Results are reported as mean ± S.E.M. of
three independent experiments. (B) Following 24 h exposition to 21% or 1% O2, Akt
was immunoprecipitated and its kinase activity was evaluated by measuring its
ability to phosphorylate recombinant GSK-3a. A Western blot against phospho-
GSK-3a was performed. This experiment was repeated three times and a
representative blot is shown.ble. The presence of a substantial amount of transcriptional
active nuclei in hypoxic myotubes likely sustains cell functions.
Moreover, the altered cell viability reported at 48 h cannot entirely
explain the 49% decline observed in protein synthesis including the
early alteration seen in IGF/PI3K/Akt pathway. Although we are
conﬁdent with the interpretation of these results, 48 h of hypoxic
exposure on L6 myotubes is likely the limit of this model to study
protein homeostasis. Thus, in addition to the increased protein
degradation, there is a subsequent reduction in the regeneration
of muscle protein content under hypoxic conditions. This adapta-
tive response to hypoxia could explain the loss of 26% of total pro-
tein content observed in hypoxic myotubes and support the notion
that hypoxia has the potential to contribute to muscle atrophy. To
further describe the effects of hypoxia on muscle cells, we mea-
sured the activation state of the IGF/PI3K/Akt pathway. Upon phos-Fig. 7. GSK-3b phosphorylation level is diminished in hypoxia. Myotubes were
incubated to 21% or 1% O2 for 24 h. Whole cell extracts were blotted for phospho-
GSK-3b and total GSK-3b. The 21% O2 condition set at 100% and compared to
hypoxic exposures. Data are presented as phospho-GSK-3b/total GSK-3b ratios.
Results are reported as mean ± S.E.M. of three independent experiments. *P < 0.05.
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the generation of signals in favor of protein synthesis [9]. In hyp-
oxic conditions, we found a decrease in Akt kinase activity, sug-
gesting that the IGF/PI3K/Akt pathway activity is reduced in
hypoxia. The total Akt reduction is probably contributing to this
low synthesis state in hypoxic myotubes. Interestingly, this result
has also been reported in peripheral muscle of subjects with mus-
cle atrophy [18]. Potential explanations for this reduction could be
the inability to properly translate Akt mRNA into functional pro-
tein or post-translational modiﬁcations of Akt affecting its stability
and promoting its degradation [21]. GSK-3b, a target of Akt, was
also hypophosphorylated after 24 h of hypoxic exposure. This
observation also supports the concept that IGF-1/PI3K/Akt path-
way activity is lowered in hypoxic myotubes.
4.3. Contractile protein homeostasis: integration
Cells undergoing hypoxic stress modify their form and function
to maintain homeostasis. Of interest is the size reduction that oc-
curs in organisms adapting to low O2 environment [17]. Consistent
with this notion, protein content was decreased in hypoxic myotu-
bes, suggesting that these cells are undergoing atrophy. Based on
our results, it is interesting to note that both protein degradation
and synthesis are contributive to this cell remodeling, in an asyn-
chronous manner. We propose a model conceptualizing this notion
into two successive intricate moments (Fig. 8). When cells are ex-
posed to hypoxia, increased protein degradation is the ﬁrst cell re-
sponse. This situation, where protein degradation outweighs
protein synthesis, leads to a net protein loss (T1). Further progres-
sion in time conducts to a decrease in protein synthesis below the
level observed in normoxia, leading to a further reduction in pro-
tein content in hypoxic myotubes and an inability to synthesize
sufﬁcient proteins to overcome the previous loss (T2).
Overall, these results are in strong agreement with the notion
that hypoxia is acting as a catabolic trigger on muscle cells. Muscle
volume balance is an important biological issue in living organisms
and better understanding of the mechanisms leading to muscle
atrophy is necessary to reverse its adverse effects. Here we demon-
strate that hypoxia is an additional factor to consider in this com-
plex equation.Fig. 8. Protein degradation and synthesis are sequentially activated in hypoxic
myotubes. Protein degradation is increased in the ﬁrst part (T1) of chronic hypoxic
exposure. This situation brings an imbalance in protein homeostasis where protein
degradation outweighs protein synthesis, which leads to a net protein loss. When
the hypoxic exposure continues (T2), protein synthesis is decreased below
normoxic level in hypoxia, still creating an imbalance in protein homeostasis.Acknowledgements
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